(XC) WisdomTree Emerging Markets - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US97717Y5353
XC: Emerging, Market, Stocks, Excluding, China
The WisdomTree Emerging Markets ex-China Fund (NYSE ARCA:XC) is an exchange-traded fund (ETF) that tracks a modified float-adjusted market cap weighted index, focusing on common stocks from emerging markets, excluding companies incorporated or domiciled in China. This strategic exclusion allows the fund to capitalize on growth opportunities in emerging economies outside of China, potentially reducing exposure to specific geopolitical and economic risks associated with Chinese companies.
By investing at least 80% of its total assets in component securities of the index and similar investments, the fund aims to replicate the indexs performance. The non-diversified nature of the index means it may be more susceptible to volatility due to its concentration in specific stocks or sectors, but it also allows for a more focused investment approach in emerging markets outside of China.
Analyzing the
From a
Forecasting the funds performance, considering both
Given the 52-week high of $33.94 and low of $26.82, the current price of $32.55 is near the upper end of this range, suggesting that while there may be potential for further growth, the fund is relatively close to its recent peak. Investors should be aware of potential resistance at this level and consider the overall market conditions and emerging markets trends before making investment decisions.
Additional Sources for XC ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
XC ETF Overview
Market Cap in USD | 87m |
Category | Diversified Emerging Mkts |
TER | 0.32% |
IPO / Inception | 2022-09-20 |
XC ETF Ratings
Growth Rating | 39.5 |
Fundamental | - |
Dividend Rating | 36.4 |
Rel. Strength | -5.08 |
Analysts | - |
Fair Price Momentum | 31.87 USD |
Fair Price DCF | - |
XC Dividends
Dividend Yield 12m | 1.06% |
Yield on Cost 5y | 1.48% |
Annual Growth 5y | 48.21% |
Payout Consistency | 100.0% |
Payout Ratio | % |
XC Growth Ratios
Growth Correlation 3m | 95.4% |
Growth Correlation 12m | -25.8% |
Growth Correlation 5y | 88.9% |
CAGR 5y | 14.77% |
CAGR/Max DD 5y | 0.70 |
Sharpe Ratio 12m | 0.87 |
Alpha | -3.61 |
Beta | 0.780 |
Volatility | 16.92% |
Current Volume | 10.1k |
Average Volume 20d | 4.5k |
As of July 01, 2025, the stock is trading at USD 34.42 with a total of 10,098 shares traded.
Over the past week, the price has changed by +4.15%, over one month by +7.08%, over three months by +16.48% and over the past year by +8.88%.
Partly, yes. Based on ValueRay´s Analyses, WisdomTree Emerging Markets (NYSE ARCA:XC) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 39.51 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XC is around 31.87 USD . This means that XC is currently overvalued and has a potential downside of -7.41%.
WisdomTree Emerging Markets has no consensus analysts rating.
According to our own proprietary Forecast Model, XC WisdomTree Emerging Markets will be worth about 36.8 in July 2026. The stock is currently trading at 34.42. This means that the stock has a potential upside of +6.83%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 36.8 | 6.8% |